Tristel Regulatory News (TSTL)

3 Jan 2008 15:29

Tristel PLC03 January 2008 TRISTEL plc Grant of Patent Tristel plc ("Tristel"), the AIM listed provider of infection and contaminationcontrol products, announces that it has been granted a patent by the EuropeanPatent Office for its chlorine dioxide generation system. The new patent, EPOno 1644051, relates to Tristel's Generator which is used to dispense Tristel'sproprietary chlorine dioxide chemistry. Tristel Generators are employed in the decontamination of endoscopes in a numberof United Kingdom hospitals with Tristel products being used in over 375hospitals, representing some 60 per cent. of all UK NHS Acute & PrivateHospitals. Tristel is in the process of adapting the Generator for use in buildings' watersupply systems, enhancing the capabilities of its Tristel Technologiessubsidiary which focuses upon legionella control. Tristel operates through two subsidiaries: Tristel Solutions, which providesinfection control products based on chlorine dioxide chemistry to the healthcaremarketplace and Tristel Technologies, which uses chlorine dioxide chemistry forlegionella control in buildings' water systems (including those of hospitals)and contamination control in the food growing and processing industries. Contacts: Tristel plc Paul Swinney, Chief Executive Tel: 01638 721 500 Daniel Stewart & Company PlcOliver Rigby Tel: 020 7776 6550 Parkgreen Communications Ltd Tel: 020 7851 7480Paul McManus Mob: 07980 541 893 paul.mcmanus@parkgreenmedia.com This information is provided by RNS The company news service from the London Stock Exchange